Cresco Labs Inc. (CRLBF): Operating Cash Flow

Annual figures by period end, from SEC filings.

$72.89M
Year ended 2025-12-31
$132.48M2023-12-31: $58.56M2024-12-31: $132.48M2025-12-31: $72.89M$72.89M
2023-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$72.89M-45.0%2026-03-06, From 2025-01-01
2024-12-31$132.48M+126.2%2026-03-06, From 2024-01-01
2023-12-31$58.56Mn/a2025-03-14, From 2023-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$72.89M-45.0%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$38.05M-48.1%
Tilray Brands, Inc. (TLRY)2026-05-31-$69.14Mn/m
USANA Health Sciences Inc (USNA)2026-01-03$22.35M-63.4%
Trulieve Cannabis Corp. (TRLV)2025-12-31$272.82M+0.5%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$137.71M-15.8%
Jushi Holdings Inc. (JUSH)2025-12-31$17.73M-17.8%
biote Corp. (BTMD)2025-12-31$35.19M-22.2%
Glass House Brands Inc. (GLAS)2025-12-31$11.45M-59.7%

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗